Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Fabbrini

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
Headache|March 31, 2001
Impact of the International Headache Society criteria on the use of neuroimaging for headache diagnosis in a headache clinicG Fabbrini, P Barbanti, M P Pascali, et al.
Neurology|April 13, 2005
Headache in cranial and cervical dystoniaP Barbanti, G Fabbrini, C Pauletti, et al.
Italian Journal of Neurological Sciences|February 1, 1997
Anticipation of onset age in hereditary essential tremorM Bragoni, G Fabbrini, S Di Legge, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 5, 2003
Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatmentG Fabbrini, P Barbanti, C Aurilia, et al.
European Journal of Neurology|October 12, 2018
Disease progression in blepharospasm: a 5-year longitudinal studyG Ferrazzano, A Conte, A Gigante, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1989
Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disordersA Braun, M M Mouradian, E Mohr, et al.
Archives of Neurology|October 1, 1987
Dietary influences on the antiparkinsonian response to levodopaJ L Juncos, G Fabbrini, M M Mouradian, et al.
Biological Psychiatry|June 20, 1998
Antipanic effect of fluoxetine measured by CO2 challenge testV Bocola, M D Trecco, G Fabbrini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 12, 2002
Donepezil in the treatment of hallucinations and delusions in Parkinson's diseaseG Fabbrini, P Barbanti, C Aurilia, et al.
Neurology|July 1, 1987
Levodopa methyl ester treatment of Parkinson's diseaseJ L Juncos, M M Mouradian, G Fabbrini, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Headache|March 31, 2001
Impact of the International Headache Society criteria on the use of neuroimaging for headache diagnosis in a headache clinicG Fabbrini, P Barbanti, M P Pascali, et al.
Neurology|April 13, 2005
Headache in cranial and cervical dystoniaP Barbanti, G Fabbrini, C Pauletti, et al.
Italian Journal of Neurological Sciences|February 1, 1997
Anticipation of onset age in hereditary essential tremorM Bragoni, G Fabbrini, S Di Legge, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 5, 2003
Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatmentG Fabbrini, P Barbanti, C Aurilia, et al.
European Journal of Neurology|October 12, 2018
Disease progression in blepharospasm: a 5-year longitudinal studyG Ferrazzano, A Conte, A Gigante, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1989
Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disordersA Braun, M M Mouradian, E Mohr, et al.
Archives of Neurology|October 1, 1987
Dietary influences on the antiparkinsonian response to levodopaJ L Juncos, G Fabbrini, M M Mouradian, et al.
Biological Psychiatry|June 20, 1998
Antipanic effect of fluoxetine measured by CO2 challenge testV Bocola, M D Trecco, G Fabbrini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 12, 2002
Donepezil in the treatment of hallucinations and delusions in Parkinson's diseaseG Fabbrini, P Barbanti, C Aurilia, et al.
Neurology|July 1, 1987
Levodopa methyl ester treatment of Parkinson's diseaseJ L Juncos, M M Mouradian, G Fabbrini, et al.
Pageof 12